Optimal duration of antithrombotic therapy in carcer patients with deep vein thrombosis: the role of residual vein thrombosis. the cancer dacus

Siragusa S; Malato A; Cigna V; Arcara C; Ageno W; Ghirarduzzi A; Cormaci O; Mandala' M

Risultato della ricerca: Paper

Lingua originaleUndefined/Unknown
Stato di pubblicazionePublished - 2006

Cita questo

Siragusa S; Malato A; Cigna V; Arcara C; Ageno W; Ghirarduzzi A; Cormaci O; Mandala' M (2006). Optimal duration of antithrombotic therapy in carcer patients with deep vein thrombosis: the role of residual vein thrombosis. the cancer dacus.

Optimal duration of antithrombotic therapy in carcer patients with deep vein thrombosis: the role of residual vein thrombosis. the cancer dacus. / Siragusa S; Malato A; Cigna V; Arcara C; Ageno W; Ghirarduzzi A; Cormaci O; Mandala' M.

2006.

Risultato della ricerca: Paper

Siragusa S; Malato A; Cigna V; Arcara C; Ageno W; Ghirarduzzi A; Cormaci O; Mandala' M 2006, 'Optimal duration of antithrombotic therapy in carcer patients with deep vein thrombosis: the role of residual vein thrombosis. the cancer dacus'.
@conference{6029a9504ae242e5be2ae2c76ad4629c,
title = "Optimal duration of antithrombotic therapy in carcer patients with deep vein thrombosis: the role of residual vein thrombosis. the cancer dacus",
author = "{Siragusa S; Malato A; Cigna V; Arcara C; Ageno W; Ghirarduzzi A; Cormaci O; Mandala' M} and Sergio Siragusa and Arcara, {Carmelo Carlo} and Alessandra Malato",
year = "2006",
language = "Undefined/Unknown",

}

TY - CONF

T1 - Optimal duration of antithrombotic therapy in carcer patients with deep vein thrombosis: the role of residual vein thrombosis. the cancer dacus

AU - Siragusa S; Malato A; Cigna V; Arcara C; Ageno W; Ghirarduzzi A; Cormaci O; Mandala' M

AU - Siragusa, Sergio

AU - Arcara, Carmelo Carlo

AU - Malato, Alessandra

PY - 2006

Y1 - 2006

UR - http://hdl.handle.net/10447/14549

M3 - Paper

ER -